Legal

ClinoView Terms of Service

Last updated: August 10, 2026

ClinoView LLC — Version 2.0 — Last updated: August 10, 2026

Plain-English summary (not part of the contract). ClinoView is software that helps clinics collect patient intake, score it, and produce visit-ready reports. You own your data, and you can ask us for a copy of it. We process it only to run the Service. Our AI features are decision support — they never make a clinical decision, and a qualified professional must review every output. Subscriptions are month-to-month; cancel any time and access runs to the end of the period you paid for. You are responsible for clinical decisions, and for licensing any questionnaires you bring to the platform yourself. The numbered sections below are the binding agreement.

1. Agreement to These Terms

By accessing, subscribing to, paying for, or using the Services, you agree to these Terms of Service ("Terms"). If you accept these Terms on behalf of a clinic, practice, or organization, you represent that you are authorized to bind that organization, and "Customer" means that organization.

If you do not agree to these Terms, do not use the Services.

2. Eligibility and Authority

To use the Services, you must:

  • Be at least 18 years old.
  • Be a licensed healthcare professional, clinic, or organization authorized to handle

patient information under the law that applies to you.

  • Have authority to enter into a binding agreement on behalf of your organization, if you

are subscribing on its behalf.

ClinoView may decline or discontinue service to any person or organization at its discretion.

3. Definitions

  • "ClinoView," "we," "us" means ClinoView LLC, a Florida limited liability company.
  • "Services" means the ClinoView software platform, tools, and features described in

Section 4, together with any related support.

  • "Customer," "you" means the individual, clinic, practice, or organization that

subscribes to or uses the Services.

  • "Customer Data" means all patient records, clinical information, intake responses,

uploaded files, notes, and other data submitted to or generated through the Services by the Customer or its Users.

  • "Personal Data" means information relating to an identified or identifiable person

processed through the Services, including health information.

  • "Users" means individuals the Customer authorizes to access the Services under its

account.

  • "Subscription" means the Customer's right to access the Services during a paid

billing period.

  • "Subprocessor" means a third party we engage to process Personal Data in order to

provide the Services.

  • "Terms" means this document together with the Privacy Policy, the Refund &

Cancellation Policy, and any Data Processing Agreement, Business Associate Agreement, or written order form executed between the parties.

4. The Services

ClinoView provides a cloud-based software platform that supports clinical and administrative workflows, including:

  • Digital patient intake
  • Clinical workflow management
  • AI-assisted report generation
  • Clinical document analysis
  • Patient record management
  • Multi-user access and role-based permissions
  • Clinical dashboards and reporting

What the Services are and are not. ClinoView does not practice medicine and does not provide medical advice. The Services produce provisional clinical content — including structured classifications, scores, severity and risk indicators, and suggested topics for further evaluation — as decision support for a qualified healthcare professional. That output is never a final diagnosis, prescription, or treatment decision. It has no clinical effect unless and until a qualified professional independently reviews it and adopts it under their own judgment and responsibility. See Sections 17 and 18.

We may add, change, or discontinue features from time to time. We will make reasonable efforts to give advance notice of changes that materially reduce core functionality.

5. Accounts and Users

5.1 Account creation. You must provide accurate, complete information and keep it current.

5.2 Account security. You are responsible for keeping credentials confidential, for all activity under your account, and for notifying us promptly at support@clinoview.com if you suspect unauthorized access. We are not liable for losses resulting from your failure to safeguard credentials.

5.3 Users. You may authorize Users to access the Services under your account. You are responsible for their compliance with these Terms and for managing their access rights, including removing access promptly when a User leaves your organization.

6. Subscription Scope

6.1 One Subscription per entity. A Subscription covers the single legal entity or clinic identified at purchase. It may not be shared with or extended to other clinics, branches, affiliates, or separate organizations without a separate Subscription or our written authorization.

6.2 Multiple locations. If you operate multiple locations or entities and want to use the Services across them, each requires its own Subscription unless we agree otherwise in writing.

7. Free Trials

We may offer free or discounted trial access. Trials are provided as-is and may be modified or ended by us at any time. A trial does not expire automatically or convert into a paid Subscription on its own: a paid Subscription begins only when you complete payment under Section 8. Where a trial end date is communicated to you, we may deactivate the account after that date. We will make trial data available for export before any deletion, following Sections 26 and 27. During a free trial, our aggregate liability under Section 28 is limited to one hundred U.S. dollars (USD 100).

8. Fees and Billing

8.1 Fees. Applicable fees are presented to you before you subscribe and accepted at purchase, or set out in a written order form. Fees may include a recurring base subscription fee and usage-based charges (for example, charges tied to newly created patients in a billing period). Patients already registered in your account do not generate additional creation charges in later months. Patients imported as part of an agreed initial migration or historical data load do not count as newly created patients, unless agreed otherwise in writing. All fees are in U.S. dollars.

8.2 Price changes. Where we have agreed in writing to a fixed-price or promotional period, we will not change the agreed fees during that period. Otherwise, we may update fees for future billing periods with at least thirty (30) days' prior notice. If you cancel and later reactivate, the prices then in effect apply unless agreed otherwise in writing. We may change our standard prices and plans for new customers at any time.

8.3 Automatic billing. By subscribing, you authorize us to charge your payment method on a recurring monthly basis for the base fee and any usage-based charges. Each charge is accompanied by an itemized invoice.

8.4 Failed payments. If a payment fails, we will notify you. If the balance remains outstanding more than fifteen (15) days after the due date, we may restrict the account to read-only access. Continued non-payment may lead to suspension or termination under Sections 24 and 25. You are responsible for keeping payment details accurate and current; we are not liable for interruptions caused by invalid payment details.

8.5 Automatic renewal. Subscriptions renew automatically at the end of each billing period unless cancelled under Section 25. By subscribing, you authorize the charge for each renewal period.

9. Taxes

All fees are exclusive of taxes. You are responsible for all applicable taxes, withholdings, duties, and levies imposed in connection with the Services, except taxes based on our net income. Where we are required to collect tax, it will be added to the invoice.

10. Customer Data and Ownership

You own all Customer Data. We claim no ownership of it.

You grant us a limited, non-exclusive license to host, process, transmit, and display Customer Data solely to provide, secure, and support the Services, and as otherwise permitted by the Privacy Policy.

We do not sell Customer Data and do not use it for any purpose unrelated to delivering the Services. We may use aggregated, de-identified data that cannot reasonably be used to identify any individual, Customer, or patient to operate and improve the Services.

11. Privacy Responsibilities

11.1 Your responsibilities. You are solely responsible for obtaining all required patient consents and authorizations before collecting or uploading information through the Services; for complying with the privacy, data protection, and healthcare laws that apply to your practice; and for ensuring your use of the Services fits your legal and professional obligations.

11.2 Our responsibilities. We handle Customer Data in accordance with our Privacy Policy, available at https://clinoview.com/privacypolicy and incorporated into these Terms. As between the parties, you are the controller of patient Personal Data and we are the processor, acting on your documented instructions.

11.3 Data Processing Agreement. We offer a standard Data Processing Agreement ("DPA") covering purposes of processing, categories of data, security measures, each party's obligations, and the cross-border transfer mechanism required by your jurisdiction. Request it at privacy@clinoview.com; we will not require you to negotiate bespoke terms to obtain it. If a DPA is executed it forms part of these Terms, and it prevails over these Terms with respect to the processing of Personal Data.

12. HIPAA

The standard self-service configuration is not authorized for protected health information subject to HIPAA. If you are a "covered entity" or "business associate" as defined under the U.S. Health Insurance Portability and Accountability Act ("HIPAA"), you may submit protected health information only after ClinoView confirms to you in writing that a Business Associate Agreement ("BAA") is in effect between the parties and that a HIPAA-eligible account configuration has been enabled for you. Accepting these Terms, or completing payment, does not by itself provide that confirmation. Request a BAA at legal@clinoview.com. Where a BAA is executed, it controls over these Terms with respect to protected health information.

13. Security

We store information processed through the Services on infrastructure located in the United States, using cloud providers with enterprise-grade security controls.

We implement reasonable technical and organizational measures to protect the confidentiality, integrity, and availability of Customer Data, including:

  • TLS encryption for data in transit and provider-managed encryption for infrastructure

storage at rest

  • Additional application-layer AES-256 encryption of direct patient identifiers, intake

payloads, and clinical notes. Not every clinical or analytics field receives application-layer encryption; structured classification and score fields are stored in a queryable form by design

  • Customer Data is held in a shared multi-tenant environment and separated by

authenticated, role-based, clinic-scoped application access controls

  • Logging of authentication and selected administrative events
  • Regular backups with documented and periodically exercised recovery procedures

Our security program is designed using industry-recognized practices for protecting health information, including principles consistent with the HIPAA Security Rule as a design and operational reference. This describes our design standard; it is not, by itself, a certification of compliance with any framework.

You are responsible for the security of your own credentials and for configuring User access appropriately within the platform.

14. Subprocessors

You authorize us to engage Subprocessors to provide the Services. We maintain a current list of Subprocessors (name, country of processing, and function) and make it available on request at privacy@clinoview.com.

We impose data-protection obligations on each Subprocessor no less protective than those in these Terms and any applicable DPA, and we remain responsible for their performance. We will give reasonable advance notice of a new or replacement Subprocessor where practicable, and a Customer with an executed DPA may object on reasonable data-protection grounds under the process set out in that DPA.

Where AI models are used to generate reports or analyze documents, processing is limited to the data reasonably necessary for that purpose. We require those providers to process Personal Data only to provide the requested service and not to use it to train or improve their models, except as disclosed in the Privacy Policy or an applicable DPA.

15. Security Incidents

We will notify you without undue delay and, where feasible, within twenty-four (24) hours after becoming aware of a suspected or confirmed security incident that compromises the confidentiality, integrity, or availability of Personal Data processed on your behalf. We will not delay the initial notice pending completion of our investigation; we may provide information in phases and will supplement the notice promptly as facts develop. The notice will include the information reasonably available to us to help you meet your own notification obligations. Where a DPA or BAA applies, its notice terms control if they are shorter or stricter.

16. Confidentiality

16.1 Mutual obligation. Each party may receive confidential information from the other. Each party agrees to keep it confidential, use it only to exercise rights or perform obligations under these Terms, and not disclose it to third parties without prior written consent, except as required by law.

16.2 Exclusions. These obligations do not apply to information that is or becomes public through no fault of the receiving party, was already known to the receiving party, is independently developed without reference to the confidential information, or must be disclosed by law or court order (with prompt notice where permitted).

16.3 Customer Data. We treat all Customer Data as your confidential information and will not use or disclose it except as permitted by these Terms, the Privacy Policy, and any applicable DPA or BAA.

17. Artificial Intelligence

Some features use artificial intelligence to assist with report generation, document analysis, and workflow automation.

  • AI output is decision support. It may include provisional classifications, scores, risk

indicators, and suggested next steps for a professional to consider. It is not medical advice, a final diagnosis, a prescription, or a treatment decision, and it acquires clinical meaning only when a qualified professional reviews, corrects where necessary, and adopts it under their own judgment.

  • AI output may contain errors, omissions, or inaccuracies, and must be reviewed and

validated by a qualified healthcare professional before use for any clinical purpose.

  • We do not warrant the accuracy, completeness, or suitability of any AI output for any

particular clinical use.

  • The Services are not a substitute for clinical examination, and are not intended for

emergency use or for autonomous operation without professional review.

You and your healthcare professionals are solely responsible for all decisions made using or in reliance on AI-generated content.

18. Clinical Responsibility

We provide software that supports administrative and clinical workflows, including infrastructure for capture, scoring, analysis, and report generation from clinical data. The Services may propose classifications and next steps for professional consideration, but ClinoView does not practice medicine, does not issue diagnoses or prescriptions, and makes no clinical decision for any patient. Every clinical determination is made by the Customer's qualified healthcare professionals.

You and your qualified healthcare professionals are solely responsible for all patient care decisions; for the clinical accuracy of documentation created or generated through the Services; and for ensuring the Services are used appropriately within your clinical and regulatory context.

Nothing in these Terms creates a provider-patient relationship between ClinoView and any individual.

19. Clinical Instruments

The Services may be used to administer, score, or analyze clinical instruments, questionnaires, validated scales, and evaluation tools. You are solely responsible for selecting instruments appropriate to your clinical context, for obtaining all licenses, permissions, and authorizations required to use any third-party instrument, and for complying with the copyright and licensing terms attached to it.

You own and control your questionnaire. You decide which questions your patients are asked. You may adopt our standard configuration as-is, modify it, or supply your own questions and instruments for us to load on your instruction. ClinoView provides the software that administers and scores whatever you choose; we do not decide your clinical content.

Our standard configuration contains no third-party instrument that requires a commercial licence. It uses public-domain and freely usable content, so a clinic that adopts it as-is takes on no instrument licensing obligation.

Responsibility follows the source of the content. You are responsible for obtaining the rights, licences and permissions for any instrument content that you supply, select from your own licensed source, or instruct us to load — including any licence fees and any third-party rights attaching to it. We are responsible for the rights to the content of our standard configuration. Where a configuration is offered only as an unlicensed demonstration template, we will identify it as such, and it must not be used with patients unless you hold the necessary permission.

We do not otherwise endorse or sublicense third-party clinical instruments. Obligations arising from instrument content you supply — including license fees and third-party rights — are your responsibility.

20. Acceptable Use

You agree to use the Services lawfully and in accordance with these Terms. You must not:

  • Use the Services in violation of any applicable law or regulation.
  • Upload or transmit malicious code or harmful content.
  • Attempt to gain unauthorized access to our systems or to another customer's data.
  • Reverse engineer, decompile, or attempt to extract the source code of the Services.
  • Resell, sublicense, or make the Services available to third parties without our written

consent.

  • Use the Services to store or process data in ways that violate applicable privacy or

healthcare laws.

  • Interfere with, disrupt, or impair the Services or other users' access to them.

We may suspend or terminate accounts that violate this Section, as described in Sections 24 and 25.

21. Intellectual Property

21.1 Our IP. The Services — including all software, interfaces, documentation, models, and underlying technology — are owned by ClinoView or its licensors. Nothing in these Terms transfers intellectual property rights to you. You receive a limited, non-exclusive, non-transferable, revocable license to access and use the Services during the Subscription period for your internal clinical and administrative operations.

21.2 Feedback. If you give us feedback, suggestions, or ideas about the Services, we may use them without restriction or compensation. This applies only to the feedback itself, and never to Customer Data, patient information, or your confidential information, which remain governed by Sections 10 and 16 regardless of how they reach us.

22. Service Availability and Support

We will use commercially reasonable efforts to keep the Services available and to respond promptly to support requests submitted to support@clinoview.com. We will give advance notice of planned maintenance where reasonably practicable, and we maintain periodic backups and documented recovery procedures.

The Services may be unavailable from time to time due to maintenance, third-party infrastructure failures, or events outside our reasonable control. We do not commit to a specific uptime percentage, response time, or service credit under these Terms. A service level agreement applies only if separately agreed in writing.

23. Disclaimer of Warranties

EXCEPT AS EXPRESSLY STATED IN THESE TERMS, THE SERVICES ARE PROVIDED "AS IS" AND "AS AVAILABLE." TO THE MAXIMUM EXTENT PERMITTED BY LAW, CLINOVIEW DISCLAIMS ALL OTHER WARRANTIES, EXPRESS OR IMPLIED, INCLUDING IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, TITLE, AND NON-INFRINGEMENT, AND ANY WARRANTIES ARISING FROM COURSE OF DEALING OR USAGE OF TRADE. CLINOVIEW DOES NOT WARRANT THAT THE SERVICES WILL BE UNINTERRUPTED, ERROR-FREE, OR COMPLETELY SECURE, OR THAT ANY OUTPUT WILL BE ACCURATE OR SUITABLE FOR A PARTICULAR CLINICAL PURPOSE. THIS SECTION DOES NOT LIMIT ANY WARRANTY THAT CANNOT BE DISCLAIMED UNDER APPLICABLE LAW.

24. Suspension

We may suspend access to the Services, in whole or in part, if payment is overdue by more than fifteen (15) days (read-only access first, with full suspension possible on continued non-payment); if you are in material breach of these Terms; or if we reasonably believe your use poses a security risk or violates applicable law. We will give notice before suspension where reasonably practicable, and will restore access promptly once the issue is resolved.

25. Term and Termination

25.1 Cancellation by you. You may cancel your Subscription at any time through the billing portal or by emailing support@clinoview.com. Cancellation takes effect at the end of the current billing period, and you keep access until then. Fees already paid are non-refundable except as required by law, and partial billing periods are not prorated. Usage-based charges accrued during the final billing period will be invoiced on cancellation. The Refund & Cancellation Policy at https://clinoview.com/refundpolicy sets out further detail.

25.2 Termination by us. We may terminate a Subscription for convenience with thirty (30) days' notice, in which case we will refund any prepaid fees covering the period after termination takes effect; immediately if you materially breach these Terms and fail to cure within ten (10) days of notice; or immediately if required by law or to prevent harm to ClinoView, our customers, or third parties.

25.3 Effect of termination. On termination, your right to access the Services ends at the end of the applicable notice or paid period, and all accrued payment obligations remain due. The licenses granted in Sections 10 and 21.1 end on termination, except that we may continue to process Customer Data only as needed to complete an export or deletion under Sections 26 and 27. Sections 3, 9, 16, 20, 21.2, 23, 26, 27, 28, 29, 30, 32, 33, 35, and 36 survive termination, along with any other provision that by its nature should survive.

26. Data Export

Generated clinical reports can be downloaded individually as PDF from within the platform at any time. The Services do not currently provide a complete self-service export of all Customer Data in a single file.

On cancellation or termination, you may request an operator-assisted export at support@clinoview.com. We will confirm scope, format, secure delivery method, and timing with you in writing before we begin, and we will provide the data in a commonly used, machine-readable format (for example JSON or CSV, with generated reports as PDF). You have ninety (90) days from the end of the Subscription to make that request, and we will retain your data for at least that period so the request can be fulfilled.

27. Data Retention and Deletion

27.1 After termination. Deletion is currently an operator-managed process rather than an automatic one, so we do not commit to a fixed deletion date. After the export window in Section 26 closes, or once you confirm in writing that your export is complete, you may request deletion at privacy@clinoview.com and we will carry it out without undue delay. Encrypted backup copies may persist for up to one (1) year under our standard backup rotation and are restored only for disaster recovery. We will issue written confirmation of deletion only once we have verified removal from both database records and file storage.

27.2 Inactive accounts. If you cease operations, close, or do not respond to authentic communications for more than ninety (90) days, we will send a final notice to your last known contact with at least thirty (30) days' warning and make a complete export available before any deletion. If we receive no response within the notice period, we may permanently delete Customer Data, except where applicable law requires continued retention — in which case we will make the data available to you for custody for as long as that obligation lasts.

27.3 System records. After deletion of clinical and patient data, we retain authentication and administrative event logs for security and compliance purposes. These contain account and access activity only, not patient clinical records, prescriptions, or medical histories. We log authentication and selected administrative events; the Services do not currently maintain a complete audit trail of every patient-record view, download, change, or transmission, and we do not commit to a fixed retention period for such records.

28. Limitation of Liability

28.1 Exclusion of indirect damages. To the maximum extent permitted by law, neither party is liable for indirect, incidental, special, consequential, exemplary, or punitive damages, including lost revenue, lost profits, lost data, lost business opportunity, or business interruption, regardless of the legal theory and even if advised of the possibility.

28.2 Aggregate cap. Except as stated in Sections 28.3 and 28.4, each party's total cumulative liability arising out of or related to these Terms will not exceed the total amount paid by the Customer to ClinoView in the twelve (12) months immediately preceding the event giving rise to the claim (the "Annual Fees"). If fewer than twelve months have elapsed, Annual Fees means the annualized amount based on the monthly average actually paid. Annual Fees include base subscription fees and usage-based fees actually paid.

28.3 Data protection and confidentiality sublimit. For damages arising from breach of confidentiality obligations or from a Personal Data security incident, each party's liability is subject to a sublimit of two (2) times the Annual Fees, applied reciprocally.

28.4 Exceptions. Nothing in these Terms limits liability for fraud, willful misconduct, death or personal injury caused by negligence, the Customer's payment obligations, or any liability that cannot be excluded or limited under applicable law. Indemnification obligations under Section 29 remain subject to the caps in Sections 28.2 and 28.3, except where the underlying conduct falls within this Section 28.4.

29. Indemnification

29.1 By you. You will defend and indemnify ClinoView and its officers, directors, employees, and agents against third-party claims, losses, damages, liabilities, and reasonable expenses (including legal fees) arising out of or related to: your selection, configuration, or use of instrument content that you supplied, selected from your own licensed source, or instructed us to load; your failure to obtain required licenses or authorizations for that content (this does not extend to instrument content we pre-install or supply); any clinical decision, diagnosis, treatment, or prescription made by you or your healthcare professionals; your violation of applicable law or third-party rights; or your breach of Section 20 (Acceptable Use). This does not apply to claims arising from defects or infringement in the platform itself, from instruments we license to you, or from our gross negligence or willful misconduct.

29.2 By us. We will defend and indemnify you against third-party claims alleging that the Services as provided by us, or instrument content we pre-install or supply, infringe that third party's intellectual property rights, provided we have sole control of the defense and you cooperate reasonably. This obligation does not apply to claims arising from content you supplied, your modification of the Services, your use of the Services in combination with anything we did not provide, or your continued use of a version after we have made a non-infringing update available to you. If the Services become, or we believe they may become, the subject of an infringement claim, we may procure the right to continue using them, modify them to be non-infringing, or terminate the affected Subscription and refund prepaid, unused fees.

29.3 Process. The party seeking indemnity must give prompt written notice of the claim, allow the indemnifying party to control the defense, and cooperate reasonably. No settlement that imposes an obligation on the indemnified party may be made without its consent, not to be unreasonably withheld. These obligations are reciprocal and subject to Section 28.

30. Force Majeure

Neither party is liable for delay or failure to perform due to events beyond its reasonable control, including natural disasters, government action, labor disputes, internet or infrastructure failures, cyberattacks, or pandemics. The affected party must notify the other promptly and resume performance as soon as reasonably possible. This does not excuse payment obligations for Services already provided.

31. Changes to These Terms

We may update these Terms. When we do, we will post the updated version with a revised "Last updated" date and give reasonable notice by email or through the platform. Material changes take effect thirty (30) days after notice. Continued use of the Services after that date constitutes acceptance. If you do not agree, you may cancel under Section 25. Where the parties have signed a written subscription agreement requiring amendments to be signed by both parties, that agreement controls to the extent of any conflict.

32. Governing Law

These Terms are governed by the laws of the State of Florida, United States, without regard to its conflict of laws principles. The United Nations Convention on Contracts for the International Sale of Goods does not apply.

33. Dispute Resolution

33.1 Good faith negotiation. Before starting formal proceedings, the parties will try in good faith to resolve any dispute through direct discussion within thirty (30) days of written notice describing the issue in reasonable detail.

33.2 Mediation. If unresolved, either party may submit the dispute to non-binding mediation before a neutral mediator. Mediation may be conducted remotely, and costs are shared equally.

33.3 Binding arbitration. Any dispute not resolved through mediation within sixty (60) days will be finally resolved by binding arbitration administered by the American Arbitration Association under its Commercial Arbitration Rules, before a single arbitrator. The seat of arbitration is Miami, Florida, and proceedings may be conducted remotely. The language is English unless the parties agree otherwise. Each party bears its own costs and the parties share administrative costs equally, without prejudice to any award of costs by the arbitrator. The arbitrator's decision is final and binding, and judgment may be entered in any court of competent jurisdiction.

33.4 Injunctive relief. Either party may seek emergency injunctive or equitable relief from a court of competent jurisdiction to prevent irreparable harm, pending arbitration.

33.5 No class actions. Disputes will be resolved on an individual basis. Neither party may bring a claim as a plaintiff or class member in a class or representative proceeding.

34. Electronic Acceptance and Authority

By accessing, subscribing to, paying for, or using the Services, you agree to these Terms. No paper signature is required. Checking a box confirming your agreement at the time of purchase constitutes electronic acceptance. Electronic signatures, scanned copies, and documents signed through electronic platforms have the same legal effect as an original signature. The person accepting these Terms on behalf of the Customer represents and warrants that they have the authority to bind that organization.

35. General

35.1 Severability. If any provision is found invalid or unenforceable, it will be limited or severed to the minimum extent necessary and the remaining provisions stay in full force.

35.2 Waiver. Failure to enforce a provision on one occasion is not a waiver of it on another. Waivers must be in writing.

35.3 Assignment. You may not assign these Terms without our prior written consent. We may assign them in connection with a merger, acquisition, sale of assets, or similar transaction. These Terms bind and benefit the parties and their permitted successors.

35.4 Independent contractors. The parties are independent contractors. These Terms create no partnership, joint venture, agency, or employment relationship.

35.5 Notices. Notices to ClinoView go to legal@clinoview.com. Notices to you go to the email address on your account or through the platform. Notice is deemed given when sent, provided no delivery failure is received.

35.6 Entire agreement. These Terms, together with the Privacy Policy, the Refund & Cancellation Policy, and any DPA, BAA, or written order form executed between the parties, are the entire agreement regarding the Services and supersede all prior proposals, negotiations, and representations on the same subject.

35.7 Language. These Terms are written in English. Any translation is provided for convenience only; the English version controls in the event of a discrepancy.

35.8 Publicity. Neither party will use the other's name or logo publicly without prior written consent, except that we may list the Customer's name and logo as a customer on our website and in sales materials, and the Customer may withdraw that permission at any time by writing to legal@clinoview.com.

36. Contact

ClinoView LLC, a Florida limited liability company.